A carregar...
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma
Proteasome inhibition forms the cornerstone of antimyeloma therapy. The first-in-class proteasome inhibitor, bortezomib, either alone or in combination with other chemotherapeutic agents, induces high overall response rates and response qualities in patients with clinically and molecularly defined h...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3102580/ https://ncbi.nlm.nih.gov/pubmed/21654882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S13838 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|